Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2018 08:00 ET | Source: Eidos Therapeutics, Inc.

Eidos Therapeutics Presents Data from its Phase 1 Clinical Trial of AG10 at the 22nd Annual Scientific Meeting of the Heart Failure Society of America

SAN FRANCISCO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) announced the presentation of results from its Phase 1 clinical trial of AG10 during a poster session...
August 23, 2018 08:00 ET | Source: Eidos Therapeutics, Inc.

Eidos Therapeutics Announces Publication of AG10 Molecular Design in Journal of Medicinal Chemistry

SAN FRANCISCO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced publication of the design and preclinical characterization of its lead product...
August 07, 2018 16:30 ET | Source: Eidos Therapeutics, Inc.

Eidos Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update

SAN FRANCISCO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in...